Role of the ubiquitin-like modifier FAT10 in protein degradation and ...

More documents

Recommendations

Info

References B. A. French, F. van Leeuwen, N. E. Riley, Q. X. Yuan, F. Bardag-Gorce, K. Gaal, Y. H. Lue, N. Marceau, and S. W. French. Aggresome formation in liver cells in response to different toxic mechanisms: role of the ubiquitin-proteasome pathway and the frameshift mutant of ubiquitin. Exp Mol Pathol, 71(3):241–246, Dec 2001. E. C. Friedberg, A. R. Lehmann, and R. P. P. Fuchs. Trading places: how do DNA polymerases switch during translesion DNA synthesis? Mol Cell, 18(5):499–505, May 2005. M. Funakoshi, T. Sasaki, T. Nishimoto, and H. Kobayashi. Budding yeast Dsk2p is a polyubiquitinbinding protein that can interact with the proteasome. Proc Natl Acad Sci U S A, 99(2):745–750, Jan 2002. A. Gallimore, T. Dumrese, H. Hengartner, R. M. Zinkernagel, and H. G. Rammensee. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med, 187(10):1647–1657, May 1998. Y.-S. Gao, C. C. Hubbert, J. Lu, Y.-S. Lee, J.-Y. Lee, and T.-P. Yao. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis. Mol Cell Biol, 27(24):8637–8647, Dec 2007. R. Garcia-Mata, Z. Bebok, E. J. Sorscher, and E. S. Sztul. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol., 146(6):1239–54., 1999. R. Garcia-Mata, Y.-S. Gao, and E. Sztul. Hassles with taking out the garbage: aggravating aggresomes. Traffic, 3(6):388–396, Jun 2002. R. N. Germain. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell, 76(2):287–299, Jan 1994. M. H. Glickman, D. M. Rubin, H. Fu, C. N. Larsen, O. Coux, I. Wefes, G. Pfeifer, Z. Cjeka, R. Vierstra, W. Baumeister, V. Fried, and D. Finley. Functional analysis of the proteasome regulatory particle. Mol Biol Rep, 26(1-2):21–28, Apr 1999. A. L. Goldberg. Protein degradation and protection against misfolded or damaged proteins. Nature, 426(6968):895–899, Dec 2003. A. L. Goldberg, P. Cascio, T. Saric, and K. L. Rock. The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol, 39(3-4):147–164, Oct 2002. D. R. Green, N. Droin, and M. Pinkoski. Activation-induced cell death in T cells. Immunol Rev, 193:70–81, Jun 2003. N. Gregersen, P. Bross, S. Vang, and J. H. Christensen. Protein Misfolding and Human Disease. Annu Rev Genomics Hum Genet, 7:103–124, Sep 2006. M. Groettrup, S. Khan, K. Schwarz, and G. Schmidtke. Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie, 83(3-4):367–372, 2001a. M. Groettrup, M. van den Broek, K. Schwarz, A. Macagno, S. Khan, R. de Giuli, and G. Schmidtke. Structural plasticity of the proteasome and its function in antigen processing. Crit Rev Immunol, 21(4):339–358, 2001b. M. Groettrup, C. Pelzer, G. Schmidtke, and K. Hofmann. Activating the ubiquitin family: UBA6 challenges the field. Trends Biochem Sci, 33(5):230–237, May 2008. M. Groll and T. Clausen. Molecular shredders: how proteasomes fulfill their role. Curr Opin Struct Biol, 13(6):665–673, Dec 2003. M. Groll, M. Bajorek, A. Köhler, L. Moroder, D. M. Rubin, R. Huber, M. H. Glickman, and D. Finley. A gated channel into the proteasome core particle. Nat Struct Biol, 7(11):1062–1067, Nov 2000. T. Grune, T. Reinheckel, and K. J. Davies. Degradation of oxidized proteins in mammalian cells. FASEB J, 11(7):526–534, Jun 1997. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Théry, and S. Amigorena. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol, 20:621–667, 2002. S. Guerra, A. Cáceres, K.-P. Knobeloch, I. Horak, and M. Esteban. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog, 4(7):e1000096, Jul 2008. 129
References S. Gunawardena, L.-S. Her, R. G. Brusch, R. A. Laymon, I. R. Niesman, B. Gordesky-Gold, L. Sintasath, N. M. Bonini, and L. S. B. Goldstein. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron, 40(1):25–40, Sep 2003. S. J. Haggarty, K. M. Koeller, J. C. Wong, C. M. Grozinger, and S. L. Schreiber. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A., 100(8):4389–94. Epub 2003 Apr 3., 2003. K. Haglund and I. Dikic. Ubiquitylation and cell signaling. EMBO J, 24(19):3353–3359, Oct 2005. J. Hanna and D. Finley. A proteasome for all occasions. FEBS Lett, 581(15):2854–2861, Jun 2007. J. Hanna, N. A. Hathaway, Y. Tone, B. Crosas, S. Elsasser, D. S. Kirkpatrick, D. S. Leggett, S. P. Gygi, R. W. King, and D. Finley. Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell, 127(1):99–111, Oct 2006. R. Hartmann-Petersen, K. B. Hendil, and C. Gordon. Ubiquitin binding proteins protect ubiquitin conjugates from disassembly. FEBS Lett, 535(1-3):77–81, Jan 2003. H. P. Hauser, M. Bardroff, G. Pyrowolakis, and S. Jentsch. A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors. J Cell Biol, 141(6):1415–1422, Jun 1998. K. B. Hendil, P. Kristensen, and W. Uerkvitz. Human proteasomes analysed with monoclonal antibodies. Biochem J, 305 ( Pt 1):245–252, Jan 1995. J. P. Hendrick and F. U. Hartl. The role of molecular chaperones in protein folding. FASEB J, 9 (15):1559–1569, Dec 1995. A. Hershko and A. Ciechanover. The ubiquitin system. Annu Rev Biochem, 67:425–479, 1998. A. Hershko, A. Ciechanover, H. Heller, A. L. Haas, and I. A. Rose. Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis. Proc Natl Acad Sci U S A, 77(4):1783–1786, Apr 1980. L. Hicke. A new ticket for entry into budding vesicles-ubiquitin. Cell, 106(5):527–530, Sep 2001. T. Hideshima, J. E. Bradner, J. Wong, D. Chauhan, P. Richardson, S. L. Schreiber, and K. C. Anderson. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci U S A., 102(24):8567–72. Epub 2005 Jun 3., 2005. D. A. Hildeman, Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity, 16(6): 759–767, Jun 2002. M. S. Hipp. NUB1L and FAT10, two ubiquitin-like proteins involved in protein degradation. PhD thesis, Universität Konstanz, 2004. M. S. Hipp, S. Raasi, M. Groettrup, and G. Schmidtke. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem., 279(16): 16503–10. Epub 2004 Feb 2., 2004. M. S. Hipp, B. Kalveram, S. Raasi, M. Groettrup, and G. Schmidtke. FAT10, a ubiquitinindependent signal for proteasomal degradation. Mol Cell Biol., 25(9):3483–91., 2005. H. Hiyama, M. Yokoi, C. Masutani, K. Sugasawa, T. Maekawa, K. Tanaka, J. H. Hoeijmakers, and F. Hanaoka. Interaction of hHR23 with S5a. The ubiquitin-like domain of hHR23 mediates interaction with S5a subunit of 26 S proteasome. J Biol Chem, 274(39):28019–28025, Sep 1999. C. Hoege, B. Pfander, G.-L. Moldovan, G. Pyrowolakis, and S. Jentsch. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature, 419(6903):135–141, Sep 2002. K. Hofmann and P. Bucher. The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem Sci, 21(5):172–173, May 1996. H. Hon, E. B. Rucker, L. Hennighausen, and J. Jacob. bcl-xL is critical for dendritic cell survival in vivo. J Immunol, 173(7):4425–4432, Oct 2004. 130
Page 1 and 2:
Role of the ubiquitin-like modifier
Page 3 and 4:
Acknowledgements . . . . . . . . .
Page 5 and 6:
Summary / Zusammenfassung English F
Page 7 and 8:
Summary In conclusion, these result
Page 9 and 10:
Summary nicht von der katalytischen
Page 11 and 12:
The Ubiquitin-Proteasome-System The
Page 13 and 14:
Introduction Figure 1: The 26S prot
Page 15 and 16:
Introduction are the major source o
Page 17 and 18:
Introduction majority of ubiquitin-
Page 19 and 20:
Introduction example contained in t
Page 21 and 22:
Introduction two modifiers apart fr
Page 23 and 24:
Introduction Figure 4: Comparison o
Page 25 and 26:
Introduction dependent apoptosis in
Page 27 and 28:
Introduction Interestingly, a recen
Page 29 and 30:
The Autophagy-Lysosome System Intro
Page 31 and 32:
Introduction Figure 5: Molecular ma
Page 33 and 34:
Introduction The transport of misfo
Page 35 and 36:
Introduction where the proteasome i
Page 37 and 38:
Chapter 1 The UBA domains of NUB1L
Page 39 and 40:
Introduction Chapter 1 Ubiquitin, a
Page 41 and 42:
Chapter 1 no correlation between th
Page 43 and 44:
Chapter 1 covered proteins were sep
Page 45 and 46:
Chapter 1 Figure 8: Accelerated deg
Page 47 and 48:
Chapter 1 Treatment with IFN-γ and
Page 49 and 50:
Chapter 1 ing SUMO-1-GFP or the C-t
Page 51 and 52:
Chapter 1 Figure 12: Accelerated de
Page 53 and 54:
Chapter 1 Figure 13: Co-immunopreci
Page 55 and 56:
Chapter 1 domains of NUB1L is requi
Page 57 and 58:
Chapter 1 Rad23 (Verma et al., 2004
Page 59 and 60:
Chapter 1 FAT10-GFP expressing vect
Page 61 and 62:
Chapter 2 Degradation of FAT10 by t
Page 63 and 64:
Introduction Chapter 2 The proteaso
Page 65 and 66:
Chapter 2 From our previous data it
Page 67 and 68:
Chapter 2 Figure 14: Purified compo
Page 69 and 70:
Chapter 2 evaluation of the NUB1L b
Page 71 and 72:
Chapter 2 teins which contain intri
Page 73 and 74:
Chapter 2 Combined with our studies
Page 75 and 76:
Chapter 2 Recombinant expression of
Page 77 and 78:
Chapter 2 et al., 2003), both at a
Page 79 and 80: Abstract Chapter 3 During misfolded
Page 81 and 82: Chapter 3 tion between the UPS and
Page 83 and 84: Chapter 3 Figure 18: HDAC6 interact
Page 85 and 86: Chapter 3 Figure 19: Both the BUZ d
Page 87 and 88: Chapter 3 of HDAC6 was required for
Page 89 and 90: Chapter 3 precipitates with HDAC6 (
Page 91 and 92: 90 Chapter 3
Page 93 and 94: Chapter 3 Figure 23: The model conj
Page 95 and 96: Chapter 3 HDAC6 is required for the
Page 97 and 98: Chapter 3 Figure 26: Both ubiquitin
Page 99 and 100: Chapter 3 also revealed endogenous,
Page 101 and 102: Chapter 3 and/or its conjugates is
Page 103 and 104: Chapter 3 (Hipp et al., 2005), pEGF
Page 105 and 106: Chapter 4 FAT10-deficient mice disp
Page 107 and 108: Chapter 4 Once the infection is cle
Page 109 and 110: Chapter 4 As both wild-type as well
Page 111 and 112: Chapter 4 Peptides. The synthetic p
Page 113 and 114: Introduction Chapter 5 Antibodies a
Page 115 and 116: Chapter 5 binant human and mouse GS
Page 117 and 118: Chapter 5 Figure 34: The antibodies
Page 119 and 120: Chapter 5 Figure 36: The antibody s
Page 121 and 122: Discussion 30 years ago, ubiquitin
Page 123 and 124: Discussion monomeric ubiquitin as w
Page 125 and 126: Discussion Alternatively, FAT10 cou
Page 127 and 128: References D. T. Akey, X. Zhu, M. D
Page 129: References Y.-H. Chiu, Q. Sun, and
Page 133 and 134: References J. A. Johnston, M. E. Il
Page 135 and 136: References F. Lévy, N. Johnsson, T
Page 137 and 138: References J.-H. Park, H.-S. Jong,
Page 139 and 140: References P. Schreiner, X. Chen, K
Page 141 and 142: References S. Vijay-Kumar, C. E. Bu
Page 143 and 144: Abbreviations aa amino acid AAA ATP
Page 145 and 146: Amino Acids Alanine Ala A Arginine
show all

Role of the ubiquitin-like modifier FAT10 in protein degradation and ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?